BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26391593)

  • 1. MicroRNA as potential biomarkers in Glioblastoma.
    Areeb Z; Stylli SS; Koldej R; Ritchie DS; Siegal T; Morokoff AP; Kaye AH; Luwor RB
    J Neurooncol; 2015 Nov; 125(2):237-48. PubMed ID: 26391593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Effects of MicroRNA-221 Expression Levels in Glioblastoma Multiforme Tumors.
    Ozdogan S; Yaltirik CK; Yilmaz SG; Akdeniz FT; Sumerkent K; Duzkalir AH; Ture U; Isbir T
    Anticancer Res; 2020 Jun; 40(6):3265-3270. PubMed ID: 32487621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
    Mercatelli N; Galardi S; Ciafrè SA
    Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small extracellular vesicles as tumor biomarkers for glioblastoma.
    Mahmoudi K; Ezrin A; Hadjipanayis C
    Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
    Ilhan-Mutlu A; Wöhrer A; Berghoff AS; Widhalm G; Marosi C; Wagner L; Preusser M
    J Neurooncol; 2013 May; 112(3):347-54. PubMed ID: 23420397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as efficient biomarkers in high-grade gliomas.
    Barciszewska AM
    Folia Neuropathol; 2016; 54(4):369-374. PubMed ID: 28139816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
    Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
    Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in NFKBIA and EGFR in glioblastoma multiforme.
    Komotar RJ; Starke RM; Connolly ES; Sisti MB
    Neurosurgery; 2011 Jun; 68(6):N14-5. PubMed ID: 21778941
    [No Abstract]   [Full Text] [Related]  

  • 10. MRI study identifies three subtypes of glioblastoma.
    Brower V
    Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA based theranostics for brain cancer: basic principles.
    Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
    J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme.
    Kaynar A; Altay O; Li X; Zhang C; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as biomarkers for human glioblastoma: progress and potential.
    Huang SW; Ali ND; Zhong L; Shi J
    Acta Pharmacol Sin; 2018 Sep; 39(9):1405-1413. PubMed ID: 29417946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
    Gao X; Jin W
    Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.
    Pu Y; Li S; Zhang C; Bao Z; Yang Z; Sun L
    J Neurooncol; 2015 Mar; 122(1):43-51. PubMed ID: 25527046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β pathway activity in glioblastoma.
    Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
    Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.
    Maggio I; Franceschi E; Gatto L; Tosoni A; Di Nunno V; Tonon C; Brandes AA
    Expert Rev Anticancer Ther; 2021 Nov; 21(11):1265-1272. PubMed ID: 34433354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation gene and microRNA expression in glioblastoma.
    Dong H; Siu H; Luo L; Fang X; Jin L; Xiong M
    BMC Genomics; 2010 Dec; 11 Suppl 3(Suppl 3):S16. PubMed ID: 21143783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.